These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease. Akel H; Ismail R; Csóka I Eur J Pharm Biopharm; 2020 Mar; 148():38-53. PubMed ID: 31926222 [TBL] [Abstract][Full Text] [Related]
28. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers. Devi PU; Manocha A; Vohora D Expert Opin Pharmacother; 2008 Dec; 9(18):3169-77. PubMed ID: 19040338 [TBL] [Abstract][Full Text] [Related]
29. Antioxidant treatment in Alzheimer's disease: current state. Gilgun-Sherki Y; Melamed E; Offen D J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988 [TBL] [Abstract][Full Text] [Related]
30. Thiopental sodium loaded solid lipid nano-particles attenuates obesity-induced cardiac dysfunction and cardiac hypertrophy via inactivation of inflammatory pathway. Zhu C; Li W; Wang X; Xue J; Zhao L; Song Y; Zhou T; Zhang M Drug Deliv; 2020 Dec; 27(1):1188-1200. PubMed ID: 32762480 [TBL] [Abstract][Full Text] [Related]
31. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100 [TBL] [Abstract][Full Text] [Related]
32. Nanoencapsulation of carotenoids within lipid-based nanocarriers. Rostamabadi H; Falsafi SR; Jafari SM J Control Release; 2019 Mar; 298():38-67. PubMed ID: 30738975 [TBL] [Abstract][Full Text] [Related]
34. A review of nanocarrier-based CNS delivery systems. Tiwari SB; Amiji MM Curr Drug Deliv; 2006 Apr; 3(2):219-32. PubMed ID: 16611008 [TBL] [Abstract][Full Text] [Related]
35. Tributyltin induces oxidative damage, inflammation and apoptosis via disturbance in blood-brain barrier and metal homeostasis in cerebral cortex of rat brain: an in vivo and in vitro study. Mitra S; Gera R; Siddiqui WA; Khandelwal S Toxicology; 2013 Aug; 310():39-52. PubMed ID: 23743147 [TBL] [Abstract][Full Text] [Related]
36. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems. Tortorella S; Karagiannis TC Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131 [TBL] [Abstract][Full Text] [Related]
37. Sivelestat-loaded nanostructured lipid carriers modulate oxidative and inflammatory stress in human dental pulp and mesenchymal stem cells subjected to oxygen-glucose deprivation. Prakash R; Mishra RK; Ahmad A; Khan MA; Khan R; Raza SS Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111700. PubMed ID: 33545859 [TBL] [Abstract][Full Text] [Related]
38. Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson's Disease. Mishra N; Sharma S; Deshmukh R; Kumar A; Sharma R Cent Nerv Syst Agents Med Chem; 2019; 19(1):46-56. PubMed ID: 30474538 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of antioxidants: scope, limitations and relevance of assays. Pinchuk I; Shoval H; Dotan Y; Lichtenberg D Chem Phys Lipids; 2012 Sep; 165(6):638-47. PubMed ID: 22721987 [TBL] [Abstract][Full Text] [Related]